News and Breakthroughs
Research scientists at Cedars-Sinai continually advance a new understanding of diseases, as well as new ideas and technologies for prevention and treatment. This diligence generates a steady stream of news about their transformational achievements and their benefits to healthcare.
A team of scientists led by Akil A. Merchant, MD, a Cedars-Sinai Cancer hematology researcher, and Rong Lu, PhD, an assistant professor of Stem Cell & Regenerative Medicine at the University of Southern California, have introduced a new genetic technology in a study of laboratory mice, published recently in Nature Communications.